MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $65.96MP/E –Yield –
MediciNova price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
MediciNova's price to sales ratio was 75.4× on Nov 11, 2026, against 66.2× a year earlier. Over the last 2 years it ranged from 7.9× to 469.4×, with a median of 76.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 75.4× | +12.1 |
| 2024 | Apr 30, 2024 | 63.3× | +30.8 |
| 2022 | Apr 29, 2022 | 32.4× | +24.3 |
| 2014 | Jul 31, 2014 | 8.1× | −443.1 |
| 2013 | Oct 31, 2013 | 451.2× | – |
See a number that looks wrong?